Background: Several studies have highlighted the prognostic value of the albumin-globulin ratio (AGR) in various kinds of cancers. Our study was designed to assess whether AGR is associated with the prognosis of gastric cancer patients. Patients and methods: A total of 507 gastric cancer patients between 2005 and 2012 were included. The AGR was defined as the ratio of serum albumin to nonalbumin and calculated by the equation: albumin/(total protein -albumin). Furthermore, AGR was divided into two groups (low and high) using the X-tile software. Survival analysis stratified by AGR groups was performed. Results: The mean survival time for each group was 36.62 months (95% CI: 33.92-39.32) for the low AGR group and 48.95 months (95% CI: 41.93-55.96, P=0.003) for the high AGR group. Patients in the high group (AGR >= 1.93) had a significantly lower 5-year mortality in comparison with the low group (AGR<1.93) (52.4% vs 78.5%, P= 0.003). The high AGR group showed obviously better overall survival than the low AGR group according to Kaplan-Meier curves (P= 0.003). Multivariate analysis showed that AGR was an independent predictive factor of prognosis in gastric patients. Conclusion: Pretreatment AGR is a significant and independent predictive factor of prognosis.
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类|3 区医学
小类|3 区生物工程与应用微生物4 区肿瘤学
最新[2023]版:
大类|4 区医学
小类|3 区生物工程与应用微生物4 区肿瘤学
第一作者:
第一作者机构:[1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China;[2]Sun Yat Sen Univ, Canc Ctr, Dept Gastr & Pancreat Surg, 651 East,Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China;
通讯作者:
通讯机构:[1]Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China;[2]Sun Yat Sen Univ, Canc Ctr, Dept Gastr & Pancreat Surg, 651 East,Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
Liu Jianjun,Chen Shangxiang,Geng Qirong,et al.Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection[J].ONCOTARGETS AND THERAPY.2017,10:2155-2162.doi:10.2147/OTT.S99282.
APA:
Liu, Jianjun,Chen, Shangxiang,Geng, Qirong,Liu, Xuechao,Kong, Pengfei...&Xu, Dazhi.(2017).Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection.ONCOTARGETS AND THERAPY,10,
MLA:
Liu, Jianjun,et al."Prognostic value of pretreatment albumin-globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection".ONCOTARGETS AND THERAPY 10.(2017):2155-2162